Application of Transversus Abdominus Plain Block, Local Subcutaneous Injection and IV Nalbuphine

Phase
Recruitment status
Participants
Lead sponsor
Egymedicalpedia
Start date
Number of sites

Summary
Approximately 1 in 5 women who undergo CS will experience severe acute postoperative pain. The severity of pain in the acute postoperative period is a significant predictor for the development of chronic pain, which occurs in 9.2%-18% of women who undergo CS. Furthermore, severe acute post-cesarean pain triples a woman's risk of developing postpartum depression and negatively affects breastfeeding and infant care. For these reasons, it is imperative to provide adequate postoperative analgesia in this patient population
Short title
Application of Transversus Abdominus Plain Block, Local Subcutaneous Injection and IV Nalbuphine
Official title
Comparative Study Between Transversus Abdominus Plain Block, Local Subcutaneous Injection in the Wound, and Intravenous Nalbuphine in Decreasing Postoperative Pain in Cesarean Section

Control arm
Active comparator
Registry reports results
Listing at source
Recruitment status
Phase
Study type
Interventional

Completion date
First posted
Registry last updated
Primary completion date
Start date

Actual participants
Participants
Participant count basis
Protocol amendments
Number of sites

Data monitoring committee
Registry sponsor category
Lead sponsor
Egymedicalpedia
Source registry
ClinicalTrials.gov

Registry ID
ClinicalTrials.gov ID
Registry record
Open registry record

Allocation
Randomised
Model
Factorial
Purpose
Treatment
Masking
Quadruple masking
Masked roles
Participants, Care providers, Investigators, Outcome assessors
Sources for study design

  1. Post Operative Pain

    Timeframe: 2 hours after the Cesarean Section till the pain relief

    The pain level of the cases is evaluated by means of the digital pain (numeric rating) scale from 0 to 10 in which 0 means "no pain" and 10 means "the worst pain" as well as the duration of pain relief

Sources for outcomes

Sex
Female
Age groups
Adults
Minimum age
20 Years
Maximum age
35 Years
Healthy volunteers
Yes

  • Pregnant women aged 20-35 years
  • Gestational age between 37-40 weeks
  • Pregnant women undergoing elective cesarean section
  • Medically free
  • Singleton pregnancy

  • Emergency cesarean section
  • Diabetic
  • Hypertensive
  • Severe anemia
  • Multiple pregnancy
  • Complication during section
Sources for eligibility

  • Al-Azhar UniversityCairo, Egypt
Sources for sites

Related records

Drugs (2)

Lead sponsors (1)

Targets (4)